Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$255.36 -0.60 (-0.23%)
At close: Sep 28, 2026 · 4:00 PM EDT

Alnylam Pharmaceuticals (ALNY) Other Non-Current Assets (2011 - 2026)

Updated

Alnylam Pharmaceuticals' Other Non-Current Assets was $65.13 million in Q2 2026, up 13.9% from $57.17 million a year earlier and up 2.5% from the prior quarter.

Analysis

Alnylam Pharmaceuticals (ALNY) Other Non-Current Assets (2011 - 2026) Analysis & Trends

At the end of FY2025, Other Non-Current Assets at Alnylam Pharmaceuticals came in at $59.46 million, down 9.0% from FY2024.

  • Other Non-Current Assets shows a five-year compound annual growth rate of 5.7% (FY2020 to FY2025).
  • In earlier years, Other Non-Current Assets was $65.31 million in FY2024 (+5.5%), $61.9 million in FY2023 (-6.3%), $66.09 million in FY2022 (+9.8%) and $60.2 million in FY2021 (+33.7%).
  • The Q2 2026 figure marks the highest quarterly Other Non-Current Assets since Q1 2025.
  • Compared with a year earlier, Other Non-Current Assets was higher in four of the last eight quarters, with an average decline of 4.9%.
  • The best year-over-year quarter for Other Non-Current Assets over five years was Q2 2022 (growth of 123.4%); the worst was Q3 2025 (a decline of 28.1%).
  • Per Business Quant data, ALNY's Other Non-Current Assets in the three quarters before Q2 2026 was $63.55 million (Q1 2026), $59.46 million (Q4 2025) and $55.84 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 14.27 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 10.73 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 4.75 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 1.25 Bn
10 Alnylam Pharmaceuticals 34.23 Bn 22.28 Bn 992.69 Mn 65.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 65.13 Mn
Mar 31, 2026 63.55 Mn
Dec 31, 2025 59.46 Mn
Sep 30, 2025 55.84 Mn
Jun 30, 2025 57.17 Mn
Mar 31, 2025 73.82 Mn
Dec 31, 2024 65.31 Mn
Sep 30, 2024 77.62 Mn
Jun 30, 2024 71.93 Mn
Mar 31, 2024 67.46 Mn
Dec 31, 2023 61.90 Mn
Sep 30, 2023 75.16 Mn
Jun 30, 2023 92.69 Mn
Mar 31, 2023 63.45 Mn
Dec 31, 2022 66.09 Mn
Sep 30, 2022 61.40 Mn
Jun 30, 2022 77.27 Mn
Mar 31, 2022 69.82 Mn
Dec 31, 2021 60.20 Mn
Sep 30, 2021 35.27 Mn
API Access

Alnylam Pharmaceuticals Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ALNY&period=max&api_key=YOUR_API_KEY